Selleck Chemicals FDA-approved Anticancer Drug Library

Friday, 04 April, 2025 | Supplied by: Sapphire Bioscience


Selleck Chemicals (SelleckChem) offers a collection of 1734 approved drugs with potential anticancer activity, suitable for use in high-throughput screening (HTS) and high-content screening (HCS). All drugs are from approved institutions such as the FDA, EMA, HMA, CFDA and PMDA, or pharmacopoeia such as USP, BP, EP, JP, etc.

With bioactivity and safety confirmed by clinical trials, the drug library is structurally diverse, medicinally active and cell permeable. It has been cited in over 300 publications, with rich documentation with structure and customer reviews, and has been NMR and HPLC validated for high purity.

The library consists of 1559 compounds pre-dissolved in 10 mM DMSO, 112 compounds pre-dissolved in 10 mM water, 54 compounds pre-dissolved in 2 mM DMSO and nine compounds pre-dissolved in 2 mM water. Each library is supplied in a 96 deep well plate format sealed with aluminium foil. The DMSO-dissolved compounds are stable for 12 months at -20°C or 24 months at -80°C.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

Bioss In Vivo Biosimilar Antibodies

Bioss In Vivo Biosimilar Antibodies are research-grade copies of therapeutic antibodies that are...

LSBio virology research products

LSBio offers antibodies, proteins, ELISA kits, assay kits and chemical compounds used by...

Beckman Coulter Life Sciences IR820 and IR870 infrared dye antibody conjugates

The products provide research flow cytometry labs with a low-noise solution, including single...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd